DOI: 10.36347/sajp

Pages: 356-362

Schizophrenia is a complex psychiatric illness of unsure aetiology, afflicting approximately 1% of the worldwide population. Schizophrenia generally appears between the age of 16 and 30; hence, it becomes a long-standing, chronic disease. Treatment choice are psychosocial and pharmacotherapeutical interventions. Our article represents the role and the need of pharmacists in the area of schizophrenic patient care. The recommendations are to widen the role of pharmacists and to implement it especially in the developing nations. Towards pharmaceutical care the pharmacists should have a vast knowledge in the area of drug therapy management and drug related problems. To initiate, there is a need of good association between pharmacist, psychiatrists and all other mental health care providers. Pharmacists should be kept updated with recent drug related information’s by attending regular education and training programmes. Thus, pharmacists can help the physicians, particularly, in the decision making situations. Hence, well trained and competent pharmacists can take an active role in the mental health care management team.